|
1
|
Quan J, Johnson NW, Zhou G, Parsons PG,
Boyle GM and Gao J: Potential molecular targets for inhibiting bone
invasion by oral squamous cell carcinoma: A review of mechanisms.
Cancer Metastasis Rev. 31:209–219. 2012. View Article : Google Scholar
|
|
2
|
Ziober BL, Mauk MG, Falls EM, Chen Z,
Ziober AF and Bau HH: Lab-on-a-chip for oral cancer screening and
diagnosis. Head Neck. 30:111–121. 2008. View Article : Google Scholar
|
|
3
|
Terzić J, Grivennikov S, Karin E and Karin
M: Inflammation and colon cancer. Gastroenterology.
138:2101–2114.e5. 2010. View Article : Google Scholar
|
|
4
|
Rendon BE, Willer SS, Zundel W and
Mitchell RA: Mechanisms of macrophage migration inhibitory factor
(MIF) dependent tumor microenvironmental adaptation. Exp Mol
Pathol. 86:180–185. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bach JP, Rinn B, Meyer B, Dodel R and
Bacher M: Role of MIF in inflammation and tumorigenesis. Oncology.
75:127–133. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nishihira J, Ishibashi T, Fukushima T, Sun
B, Sato Y and Todo S: Macrophage migration inhibitory factor (MIF):
Its potential role in tumor growth and tumor-associated
angiogenesis. Ann N Y Acad Sci. 995:171–182. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
França CM, Batista AC, Borra RC,
Ventiades-Flores JA, Mendonça EF, Deana AM, Mesquita-Ferrari RA, de
Natali Caly D, de Mello Rode S and Faria MR: Macrophage migration
inhibitory factor and oral cancer. J Oral Pathol Med. 42:368–373.
2013. View Article : Google Scholar
|
|
8
|
Dumitru CA, Gholaman H, Trellakis S,
Bruderek K, Dominas N, Gu X, Bankfalvi A, Whiteside TL, Lang S and
Brandau S: Tumor-derived macrophage migration inhibitory factor
modulates the biology of head and neck cancer cells via neutrophil
activation. Int J Cancer. 129:859–869. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Quan J, Elhousiny M, Johnson NW and Gao J:
Transforming growth factor-β1 treatment of oral cancer induces
epithelial-mesenchymal transition and promotes bone invasion via
enhanced activity of osteoclasts. Clin Exp Metastasis. 30:659–670.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meyer-Siegler KL, Iczkowski KA, Leng L,
Bucala R and Vera PL: Inhibition of macrophage migration inhibitory
factor or its receptor (CD74) attenuates growth and invasion of
DU-145 prostate cancer cells. J Immunol. 177:8730–8739. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qi D, Hu X, Wu X, Merk M, Leng L, Bucala R
and Young LH: Cardiac macrophage migration inhibitory factor
inhibits JNK pathway activation and injury during
ischemia/reper-fusion. J Clin Invest. 119:3807–3816. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Greven D, Leng L and Bucala R: Autoimmune
diseases: MIF as a therapeutic target. Expert Opin Ther Targets.
14:253–264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pakozdi A, Amin MA, Haas CS, Martinez RJ,
Haines GK III, Santos LL, Morand EF, David JR and Koch AE:
Macrophage migration inhibitory factor: A mediator of matrix
metallo-proteinase-2 production in rheumatoid arthritis. Arthritis
Res Ther. 8:R1322006. View
Article : Google Scholar
|
|
14
|
Kong YZ, Yu X, Tang JJ, Ouyang X, Huang
XR, Fingerle-Rowson G, Bacher M, Scher LA, Bucala R and Lan HY:
Macrophage migration inhibitory factor induces MMP-9 expression:
Implications for destabilization of human atherosclerotic plaques.
Atherosclerosis. 178:207–215. 2005. View Article : Google Scholar
|
|
15
|
Yu X, Lin SG, Huang XR, Bacher M, Leng L,
Bucala R and Lan HY: Macrophage migration inhibitory factor induces
MMP-9 expression in macrophages via the MEK-ERK MAP kinase pathway.
J Interferon Cytokine Res. 27:103–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
